PLEASE CLICK HERE to view upcoming event. Information here is outdated
29-30 Aug, 2019
Bangkok, THAILAND

Holiday Inn Bangkok Sukhumvit

"Explore & Invest in Asia’s Fast Emerging Cannabis Markets"

Thailand recently passed legislation to legalize and regulate the production of cannabis for medicinal use and for patients with a legitimate and documented medical need for cannabis. Thailand is the first country in Southeast Asia to take that step. The potential for Thailand’s legal cannabis is endless, from developing a cannabis export trade to boosting its medical tourism. Find out more on the medical cannabis investment landscape and regulatory hurdles in Thailand at CMT’s CannaBiz Invest Asia Summit in Bangkok on 29-30 Aug 2019!

According to specialist research firm -  Prohibition Partners, momentum among consumers and businesses for legalisation of cannabis for medical use is reaching “critical mass” globally and consumption of medical cannabis in Asia is likely to increase faster than in other early-adopter regions.

“In our view, while Asian investors and start-ups continue to keep an eye on legal developments in Europe and North America, western-based cannabis companies are getting ready to explore new opportunities in the Asian market,” the research firm said.

Imports of medical cannabis to be allowed  in Korea from March.  19/2/19, www.koreatimes.co.kr

Australia's medical cannabis market could surpass 15,000 patient application approvals by the end of this year, with industry revenues totaling roughly 36 million Australian dollars ($25 million), according to an analyst’s forecast.  20/3/19, www.mjbizdaily.com 

Agrios Global Holdings Ltd. Subsidiary Receives Three Permits Including Industrial Hemp Cultivation Permits in China.  7/5/19,
www.bloomberg.com

Officials in New Zealand  are currently putting together a draft bill that will outline a proposed regulatory regime for legal cannabis, which will then be put to the public in a vote at the 2020 election.  9/6/19,
www.nzherald.co.nz

WHO recommended in January 2019 that cannabis be removed from the most restrictive schedule of a 1961 treaty designed to combat drug abuse internationally.

If legalised across Asia, China and Japan would potentially be the biggest markets in terms of value, accounting for an estimated 75 per cent share in 2024, according to Prohibition Partners. That could quadruple by 2027, the research firm said.

While interest in Cannabis investment rises, access to financing/funding cannabis-related businesses remain a challenge. What are the options available?

 

Register Your Interest

 
Attend CMT’s CannaBiz Invest Asia Summit on 29-30 Aug 2019 in Bangkok to gain a first mover advantage in a burgeoning markets in Asia! Meet who’s who in the medical cannabis value chain.
  • Aurora Cannabis shares Global cannabis market outlook & investment landscape
  • Find out from Tilleke & Gibbins the medical cannabis investment landscape & regulatory hurdles in Thailand
  • Dept of Thai Traditional and Alternative Medicine, Ministry of Public Health highlights integration of medical cannabis in thai traditional medicine - a balancing game
  • Learn about China – industrial hemp cultivation & value chain investment case study from CannAcubed
  • BOL Pharma provides insights from farm to pharmaceutical products – Israel’s experience
  • Growth outlook for hemp foods, protein and the CBD market in Japan and globally by Elixinol Global
  • Hikurangi Cannabis Company shares Cannabis legislation in New Zealand: including government efforts to design world-leading medicinal cannabis and full legalisation
  • Commercialization of plant-derived cannabinoid prescription medicines to meet global demand by MGC Pharmaceuticals
  • Jacana provides views on “green green profits” - the cultivation of outdoor medical cannabis as a business model for Asia
  • Bombay Hemp Company Private Limited (BOHECO) provides update on industrial and medical cannabis investment in India – scientific and legal perspective
  • Vital panel discussion on  accessing capital markets for cannabis investments – options & challenges by MYM Nutraceuticals, Helius Therapeutics, Cannex Group & more!  
  • Blue Sky Biologicals provides insights on Hemp: beyond CBD & THC, a whole plant model
  • The Kingdom Holdings shares the future of sustainable fashion & hemp fibres industry
  • Pharmaceutical development in man-made cannabinoids by Akseera Pharma Corp
  • Outlook of medical cannabis industry in Australia
  • Potential of CBD in Beauty industry
  • Cannabis varieties and strains as well as extraction technologies
Sign up with your team to enjoy group discount. Register now or contact grace@cmtsp.com.sg for more information.

#cbizasia19